{
     "PMID": "27987060",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180112",
     "LR": "20180112",
     "IS": "1573-7365 (Electronic) 0885-7490 (Linking)",
     "VI": "32",
     "IP": "2",
     "DP": "2017 Apr",
     "TI": "Omega-3 fatty acids and mood stabilizers alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration.",
     "PG": "519-528",
     "LID": "10.1007/s11011-016-9942-7 [doi]",
     "AB": "Studies have shown that oxidative stress is involved in the pathophysiology of bipolar disorder (BD). It is suggested that omega-3 (omega3) fatty acids are fundamental to maintaining the functional integrity of the central nervous system. The animal model used in this study displayed fenproporex-induced hyperactivity, a symptom similar to manic BD. Our results showed that the administration of fenproporex, in the prevent treatment protocol, increased lipid peroxidation in the prefrontal cortex (143%), hippocampus (58%) and striatum (181%), and omega3 fatty acids alone prevented this change in the prefrontal cortex and hippocampus, whereas the co-administration of omega3 fatty acids with VPA prevented the lipoperoxidation in all analyzed brain areas, and the co-administration of omega3 fatty acids with Li prevented this increase only in the prefrontal cortex and striatum. Moreover, superoxide dismutase (SOD) activity was decreased in the striatum (54%) in the prevention treatment, and the administration of omega3 fatty acids alone or in combination with Li and VPA partially prevented this inhibition. On the other hand, in the reversal treatment protocol, the administration of fenproporex increased carbonyl content in the prefrontal cortex (25%), hippocampus (114%) and striatum (91%), and in prefrontal coxter the administration of omega3 fatty acids alone or in combination with Li and VPA reversed this change, whereas in the hippocampus and striatum only omega3 fatty acids alone or in combination with VPA reversed this effect. Additionally, the administration of fenproporex resulted in a marked increase of TBARS in the hippocampus and striatum, and omega3 fatty acids alone or in combination with Li and VPA reversed this change. Finally, fenproporex administration decreased SOD activity in the prefrontal cortex (85%), hippocampus (52%) and striatum (76%), and the omega3 fatty acids in combination with VPA reversed this change in the prefrontal cortex and striatum, while the co-administration of omega3 fatty acids with Li reversed this inhibition in the hippocampus and striatum. In conclusion, our results support other studies showing the importance of omega3 fatty acids in the brain and the potential for these fatty acids to aid in the treatment of BD.",
     "FAU": [
          "Gomes, Lara M",
          "Carvalho-Silva, Milena",
          "Teixeira, Leticia J",
          "Rebelo, Joyce",
          "Mota, Isabella T",
          "Bilesimo, Rafaela",
          "Michels, Monique",
          "Arent, Camila O",
          "Mariot, Edemilson",
          "Dal-Pizzol, Felipe",
          "Scaini, Giselli",
          "Quevedo, Joao",
          "Streck, Emilio L"
     ],
     "AU": [
          "Gomes LM",
          "Carvalho-Silva M",
          "Teixeira LJ",
          "Rebelo J",
          "Mota IT",
          "Bilesimo R",
          "Michels M",
          "Arent CO",
          "Mariot E",
          "Dal-Pizzol F",
          "Scaini G",
          "Quevedo J",
          "Streck EL"
     ],
     "AD": "Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Fisiopatologia, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Fisiopatologia, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Fisiopatologia, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. giiscaini@hotmail.com. Translational Psychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), 1941 East Road, Ste, 5102, Houston, TX, USA. giiscaini@hotmail.com. Laboratorio de Neurociencias, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Translational Psychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), 1941 East Road, Ste, 5102, Houston, TX, USA. Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA. Neuroscience Graduate Program, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, USA. Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20161216",
     "PL": "United States",
     "TA": "Metab Brain Dis",
     "JT": "Metabolic brain disease",
     "JID": "8610370",
     "RN": [
          "0 (Amphetamines)",
          "0 (Antimanic Agents)",
          "0 (Appetite Depressants)",
          "0 (Fatty Acids, Omega-3)",
          "0 (Thiobarbituric Acid Reactive Substances)",
          "2BMD2GNA4V (Lithium Carbonate)",
          "614OI1Z5WI (Valproic Acid)",
          "EC 1.15.1.1 (Superoxide Dismutase)",
          "W0194S5FOA (fenproporex)"
     ],
     "SB": "IM",
     "MH": [
          "Amphetamines/*toxicity",
          "Animals",
          "Antimanic Agents/*therapeutic use",
          "Appetite Depressants/*toxicity",
          "Behavior, Animal/*drug effects",
          "Brain Chemistry/drug effects",
          "Fatty Acids, Omega-3/*therapeutic use",
          "Hyperkinesis/chemically induced/metabolism/*psychology",
          "Lipid Peroxidation/drug effects",
          "Lithium Carbonate/therapeutic use",
          "Male",
          "Oxidative Stress/*drug effects",
          "Protein Carbonylation/drug effects",
          "Rats",
          "Rats, Wistar",
          "Superoxide Dismutase/metabolism",
          "Thiobarbituric Acid Reactive Substances/metabolism",
          "Valproic Acid/therapeutic use"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Bipolar disorder",
          "Fenproporex",
          "Mania",
          "Mood stabilizers",
          "Omega-3 fatty acids",
          "Oxidative stress"
     ],
     "EDAT": "2016/12/18 06:00",
     "MHDA": "2018/01/13 06:00",
     "CRDT": [
          "2016/12/18 06:00"
     ],
     "PHST": [
          "2016/08/18 00:00 [received]",
          "2016/12/07 00:00 [accepted]",
          "2016/12/18 06:00 [pubmed]",
          "2018/01/13 06:00 [medline]",
          "2016/12/18 06:00 [entrez]"
     ],
     "AID": [
          "10.1007/s11011-016-9942-7 [doi]",
          "10.1007/s11011-016-9942-7 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Metab Brain Dis. 2017 Apr;32(2):519-528. doi: 10.1007/s11011-016-9942-7. Epub 2016 Dec 16.",
     "term": "hippocampus"
}